AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease

RecruitingNAAges 60 Years - anyAllUniversity Hospital, Montpellier
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this Multicenter observational pilot study is to Compare the specifics of musical engagement (behaviors related to music in everyday life) in subjects aged over 60 with Alzheimer s disease, Parkinson s disease and control subjects. The main questions it aims to answer are: 1. The description of different profiles of musical engagement in early-stage AD, in PD and in healthy elderly subjects. 2. The extent of executive, mnestic and hedonic dysfunctions will impact differently on emotional engagement, autobiographical evocation and sensitivity to musical reward, and will therefore enable distinct profiles to be drawn up. Participants will have an intervention consisting of an interview with a neuropsychologist lasting approximately 2 hours, including : * A semi-structured interview to check the participants eligibility and gather demographic data. * Neuropsychological tests

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: General inclusion criteria: * 60 years and older * French-speaking and volunteering for the study * Living at home with a relative Alzheimer's disease inclusion criteria: * Biological diagnosis of probable Alzheimer's disease according to NINCDS-ADRDA criteria (McKhann et al., 1984) * MMSE greater than or equal to 20 Inclusion criteria Parkinson's disease : * Diagnosis of Idiopathic Parkinson's disease * MMSE greater than or equal to 20 Exclusion Criteria: * No known neurological pathologies (epilepsy and other non-degenerative CNS diseases) or psychiatric disorders (chronic psychosis and psychotic episodes) * Autistic disorders * History of stroke or head trauma * Unstable medical condition (cancer) * Subject unable to read and/or write * Hearing impairment without hearing aids * Refusal of consent after information * Persons unable to give consent, research carried out in emergency situations, etc.) * Non-affiliation with a social security scheme * Person deprived of liberty (by judicial or administrative decision, or forced hospitalization) * Person under legal protection (guardianship, curatorship, legal protection) * Person participating in another research project with an exclusion period still in progress
๐Ÿ’Š

What it tests

  • neuropsychologist interview
  • questionnaire
๐Ÿ“

Where

3 sites
Montpellier Seniors' Association
Montpellier, France
CHU de Montpellier - CEPMo
Montpellier, France
CHU de Montpellier - CMRR
Montpellier, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy